Manotti named senior vice president, chief development officer at MSKCC

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Kenneth Manotti has been named senior vice president and Chief Development Officer at Memorial Sloan Kettering Cancer Center.

Manotti has more than 30 years of fundraising and leadership experience at major institutions, including the University of Pennsylvania, Columbia University, the American University in Cairo, and the University of Chicago. He was senior vice president of University Development and Alumni Relations at New York University.

Manotti’s appointment concludes a national search for new leadership for MSK’s fundraising program, which was led for the past 15 years by Richard Naum as senior vice president for Development and Anne McSweeney as Special Advisor to the President.

Under their direction, the Campaign for MSK surpassed its $3.5 billion goal, providing vital support for innovation and discovery research to transform cancer treatment in New York and around the globe.

At the University of Chicago, where Manotti served as vice president for Alumni Relations and Development from 2011 to 2017, he helped direct a successful $5 billion capital campaign, working collaboratively with university leadership, trustees, and advancement colleagues.

Before that, he served as vice president for Institutional Advancement at the AUC, where he led university-wide development, alumni affairs, and marketing and communications programs in the United States, the Middle East, and Europe. Prior to his work at the AUC, he was associate dean for External Affairs at the University of Pennsylvania’s Wharton School of Business, where he directed the $550 million Wharton Campaign.

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login